CB2 Insights announces debt conversion of $3M USD held by Merida Capital and extinguishes all long-term debt liabilities

NEXT STORY
Global Microbial Identification Market (2020 to 2025) – Bioterrorism Surveillance Presents Opportunities
PREV STORY
MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Announces Publication on Anti-IL-7 Receptor Antagonist, OSE-127, in The Journal of Clinical Investigation

author_avatar
NASDAQ Market News

SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction

SciVac Therapeutics changes its name to VBI VaccinesCombined company to begin trading on The ...

author_avatar
NASDAQ Market News

Innate Pharma présente des données préliminaires de l’essai TELLOMAK montrant une réponse clinique avec lacutamab dans le mycosis fungoides

author_avatar
NASDAQ Market News